We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
901
Pursuit Attractions and Hospitality Inc
PRSU
$1.5B
| $2.02K | ﹤0.01% |
+36
| New | +$1.59K |
2026 Q2
0 quarters
|
|
902
Waystar Holding Corp
WAY
$5.52B
| $1.19K | ﹤0.01% |
58
-23,332
| -100% | -$491K |
2025 Q1
5 quarters
|
|
903
Silicon Laboratories
SLAB
$7.38B
| $874 | ﹤0.01% |
4
| – | – |
2026 Q1
1 quarter
|
|
904
Unifirst Corp
UNF
$4.82B
| $793 | ﹤0.01% |
3
-1
| -25% | -$261 |
2026 Q1
1 quarter
|
|
905
Norfolk Southern
NSC
$73.1B
| $629 | ﹤0.01% |
2
| – | – |
2026 Q1
1 quarter
|
|
906
Allstate
ALL
$63.2B
| $476 | ﹤0.01% |
+2
| New | +$435 |
2026 Q2
0 quarters
|
|
907
State Street SPDR S&P Homebuilders ETF
XHB
$1.54B
| $462 | ﹤0.01% |
+4
| New | +$419 |
2026 Q2
0 quarters
|
|
908
Welltower
WELL
$172B
| $454 | ﹤0.01% |
+2
| New | +$423 |
2026 Q2
0 quarters
|
|
909
Penumbra
PEN
$12.8B
| $316 | ﹤0.01% |
+1
| New | +$324 |
2026 Q2
0 quarters
|
|
910
DELISTED
National Storage Affiliates Trust
NSA
| $267 | ﹤0.01% |
+6
| New | +$257 |
2026 Q2
0 quarters
|
|
911
Freedom Holding
FRHC
$11B
| $261 | ﹤0.01% |
+2
| New | +$291 |
2026 Q2
0 quarters
|
|
912
DELISTED
Electronic Arts
EA
| $205 | ﹤0.01% |
1
-3
| -75% | -$608 |
2026 Q1
1 quarter
|
|
913
Boston Properties
BXP
$9.43B
| $199 | ﹤0.01% |
+3
| New | +$180 |
2026 Q2
0 quarters
|
|
914
Booking.com
BKNG
$123B
| $178 | ﹤0.01% |
+1
| New | +$171 |
2026 Q2
0 quarters
|
|
915
State Street Health Care Select Sector SPDR ETF
XLV
$46.7B
| $159 | ﹤0.01% |
1
-20,457
| -100% | -$3.04M |
2026 Q1
1 quarter
|
|
916
Salesforce
CRM
$200B
| $157 | ﹤0.01% |
+1
| New | +$176 |
2026 Q2
0 quarters
|
|
917
Origin Bancorp
OBK
$1.6B
| $153 | ﹤0.01% |
3
| – | – |
2026 Q1
1 quarter
|
|
918
Roku
ROKU
$23.4B
| $138 | ﹤0.01% |
1
-106,033
| -100% | -$12.9M |
2026 Q1
1 quarter
|
|
919
DELISTED
Apogee Therapeutics
APGE
| $133 | ﹤0.01% |
+1
| New | +$90 |
2026 Q2
0 quarters
|
|
920
Brighthouse Financial
BHF
$2.74B
| $127 | ﹤0.01% |
+2
| New | +$124 |
2026 Q2
0 quarters
|
|
921
Pacira BioSciences
PCRX
$1.45B
| $127 | ﹤0.01% |
5
-36,417
| -100% | -$861K |
2025 Q4
2 quarters
|
|
922
Synaptics
SYNA
$4.66B
| $124 | ﹤0.01% |
1
-5,793
| -100% | -$654K |
2026 Q1
1 quarter
|
|
923
Hut 8
HUT
$8.51B
| $115 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
924
Loews
L
$22.8B
| $113 | ﹤0.01% |
1
| – | – |
2026 Q1
1 quarter
|
|
925
Iridium Communications
IRDM
$4.66B
| $110 | ﹤0.01% |
+2
| New | +$85 |
2026 Q2
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.